产品说明
包装
5, 25 mg in glass bottle
生化/生理作用
BLI-489 is a penem β-lactamase inhibitor, which has shown activity against class A, C, and D β-lactamases. BLI-489 is being tested in combination therapy for drug-resistant bacteria.
其他说明
This compound was developed by Pfizer for Immunology research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer.
To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
法律信息
Sold for research purposes under agreement from Pfizer Inc.
Pfizer is a registered trademark of Pfizer, Inc.
基本信息
| 经验(实验)分子式 | C13H10N3NaO4S · xH2O |
| 分子量 | 327.29 (anhydrous basis) |
| MDL编号 | MFCD22374169 |
| PubChem化学物质编号 | 329823689 |
| NACRES | NA.77 |
产品性质
| 质量水平 | 100 |
| 测定 | ≥98% (HPLC) |
| 形式 | powder |
| manufacturer/tradename | Pfizer® |
| 颜色 | yellow |
| 溶解性 | H2O: >20 mg/mL |
| 创始人 | Pfizer |
| 储存温度 | room temp |
| SMILES string | O.[Na+].[O-]C(=O)C1=CS[C@H]2N1C(=O)\C2=C\c3cnc4COCCn34 |
| InChI | 1S/C13H11N3O4S.Na.H2O/c17-11-8(12-16(11)9(6-21-12)13(18)19)3-7-4-14-10-5-20-2-1-15(7)10;;/h3-4,6,12H,1-2,5H2,(H,18,19);;1H2/q;+1;/p-1/b8-3-;;/t12-;;/m1../s1 |
| InChI key | UAZCFKAYAYJPDM-UVEQJXRBSA-M |
安全信息
| 储存分类代码 | 11 - Combustible Solids |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
m.cnreagent.com
